Penicillin allergy evaluation in hospitalized patients with hematologic malignancy

A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactam...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Vima M., Chu, Brian, Hamilton, Keith W., Bellamy, Cassandra, Harker, Christina, Bryer, Joshua S., Shields, Bridget, Hirsh, Rebecca L., Fadugba, Olajumoke O., Micheletti, Robert G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204135/
https://www.ncbi.nlm.nih.gov/pubmed/37228506
http://dx.doi.org/10.1017/ash.2023.144
Descripción
Sumario:A penicillin allergy testing service (PATS) assessed penicillin allergy in patients with hematologic malignancies; 17 patients who met criteria had negative skin testing. Patients who underwent penicillin challenge passed and were delabeled. Of delabeled patients, 87% received and tolerated β-lactams during follow-up. Providers found the PATS valuable.

Ejemplares similares